Skip to main content

Table 2 Summary of selected FNDR HDAC inhibitors belonging to four sub-chemotypes exhibiting anti-malarial activity with their structures

From: Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria